621
Views
9
CrossRef citations to date
0
Altmetric
Diabetes

Perceptions of diabetes control among physicians and people with type 2 diabetes uncontrolled on basal insulin in Sweden, Switzerland, and the United Kingdom

, , , , &
Pages 981-989 | Received 25 Nov 2015, Accepted 22 Jan 2016, Published online: 07 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Kenneth J Tomaszewski, Amy Allen, Michelle Mocarski, Alisa Schiffman, Davida Kruger, Yehuda Handelsman, Michael Heile & Meryl Brod. (2019) Divergence in perceptions of diabetes control among patients with type 2 diabetes mellitus treated with basal insulin and health care professionals: results from the US Perceptions of Control (POC-US) study. Patient Preference and Adherence 13, pages 761-773.
Read now

Articles from other publishers (8)

Pauline Ducraux, Gérard Waeber & Pedro Marques-Vidal. (2021) Do Weight trajectories influence diabetes control? A prospective study in Switzerland (CoLaus study). Preventive Medicine Reports 23, pages 101473.
Crossref
Paulina K. Wrzal, Andrean Bunko, Varun Myageri, Atif Kukaswadia, Calum S. Neish & Noah M. Ivers. (2021) Strategies to Overcome Therapeutic Inertia in Type 2 Diabetes Mellitus: A Scoping Review. Canadian Journal of Diabetes 45:3, pages 273-281.e13.
Crossref
Mark Warren & Donna Steel. (2020) Clinical Use of IDegLira: Initiation to Titration After Basal Insulin. Clinical Diabetes 38:1, pages 62-70.
Crossref
Eden Miller, Ankur Doshi, Randi Grøn, Esteban Jódar, Petra Őrsy, Mattis F. Ranthe, Danny Sugimoto, Nikolaos Tentolouris, Adie Viljoen & Liana K. Billings. (2019) IDegLira improves patient‐reported outcomes while using a simple regimen with fewer injections and dose adjustments compared with basal–bolus therapy. Diabetes, Obesity and Metabolism 21:12, pages 2643-2650.
Crossref
Meryl Brod, Amaury Basse, Marie Markert & Kathryn M. Pfeiffer. (2019) Post-Basal Insulin Intensification and Healthcare Resource Use in Type 2 Diabetes: A Web-Based Physician Survey in the United States and United Kingdom. Diabetes Therapy 10:4, pages 1323-1336.
Crossref
Peter Wiesli & Marcus Schories. (2018) Improved Glycemic Control with Insulin Glargine 300 U/mL (Toujeo®) in Patients with Type 2 Diabetes: Real-World Effectiveness in Switzerland. Diabetes Therapy 9:6, pages 2325-2334.
Crossref
Vanita R. Aroda, Joseph R. Arulandu & Anthony J. Cannon. (2018) Insulin/Glucagon-Like Peptide-1 Receptor Agonist Combination Therapy for the Treatment of Type 2 Diabetes: Are Two Agents Better Than One?. Clinical Diabetes 36:2, pages 138-147.
Crossref
Martina Lenzen-Schulte. (2016) Lebensqualität: Was für Diabetespatienten wirklich zählt. Deutsches Ärzteblatt Online.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.